Abstract:AIM: To construct and express a eukaryotic expression plasmid containing human CD40 ligand (CD40L) in human hepatocellular carcinoma cell line HepG2 for the biological function study of CD40L on HepG2 cells. METHODS: Human CD40L cDNA was synthesized by reverse transcription-polymerase chain reaction (RT-PCR) with the specific primers from the RNA of human peripheral blood monocyte (PBMC) and directly ligated into the eukaryotic expression vector pcDNATM3.1/myc-His(-)A through digestion with specific restriction endonuclease. The recombined plasmid was transformed into the E. coli DH5a to amplify CD40L gene. Then HepG2 cells were divided into 4 groups. The cells in group A were transfected with the recombined plasmid, and group B with the blank plasmid (not containing CD40L cDNA). The cellsin group C were just normally cultured, and the ones in group D weren’t transfected but added G418 as the control for transfection. The expression of CD40L and CD40 were detected by RT-PCR and fluorescent activated cell sorter (FACS) in HepG2 cells, and the apoptosis, cell cycle, as well as Fas expression, were measured by FACS. RESULTS: The full-length human CD40L cDNA was successfully cloned into the eukaryotic vector pcDNATM3.1/myc-His(-)A. The recombinant plasmid was stably transfected into group A and the rate of CD40L expression was 39.7%. There was no CD40L expression in group B and C. The rates of CD40 expression in group A, B and C were 15.4%, 31.7% and 28.5%, respectively. The apoptotic rate of group A was 45.0±0.3%, but neither group B or C showed obvious apoptosis (P <0.01). Compared with group C, a larger proportion of cells in group A was restrained at G0/G1 phase (90.4±1.3% vs 60.6±1.5%, P <0.01), while the proportions of the cells in S phase (6.32±1.0% vs 12.0±0.7%) and G2/M phase (3.3±0.7% vs 27.3± 1.2%) were reduced (both P <0.01). The expression of Fas in group A showed marked increase as compared with that in group B and C (27.8±1.5% vs 3.2±0.8%, 4.2±1.0%, respectively, both P <0.01). CONCLUSION: The eukaryotic expression plasmid pcDNATM3.1/myc-His(-)A can be stably expressed in HepG2 cell line. CD40L-induced apoptosis of HepG2 is correlated with the increased expression of Fas and cell cycle arrest.

[Construction and Identification of Eukaryotic Co-Expression Plasmid Carrying FUS1 and Recombinant Human IL-12 Genes and Its Effection on Apoptosis of A549 Cells].

Cationic liposome mediated delivery of FUS1 and hIL-12 coexpression plasmid demonstrates enhanced activity against human lung cancer.

ANTITUMOR EFFECTS OF HUMAN IL-15 GENE MODIFIED LUNG CANCER CELL LINE

Construction of recombinant lentivirus vector containing retinoic acid-induced gene G and its effect on human lung cancer A549 cell line

Construction of FasL Sirna Expression Vector and Its Expression in Lung Cancer Cell Line A549

Construction of recombinant plasmid vector containing human survivin-1 gene and expression in lung adenocarcinoma A549 cells

Construction of recombinant encoding Hu IFN-β gene and its effect on A549 cells proliferation

Construction of Double-Subunit Co-Expression Eukaryotic Vector of Human Interleukin 12

Construction of Eukaryotic Co-expression Plasmid Harboring Genes Encoding Porphyromonas Gingivalis Fim A and Human IL-15

Construction and Identification of a Recombinant Lentiviral Vector of RNA Interference of Lung Cancer Related Gene SLC35F2

Prokaryotic Expression, Purification of a Novel Candidate Tumor Suppressor Gene FUS1 and Characterization of Its Polyclonal Antibodies

Construction of eukaryotic expression vector containing HSV-TK and IL-2 double genes and its expression in human pulmonary adenocarcinoma cell A549.

Eukaryotic Expression and Identification of Recombinant Shuttle Plasmid for Co-Expression of Human Granulysin Active Peptide and Murine IL-12

[Construction and Expression of Eukaryotic Expression Plasmid Pcdna3.1/hil-18].

Construction of FAK Sirna Expressing Vector and the Inhibitory Effects on the Expression of FAK in Lung Cancer Cell

Synergistic effects of eukaryotic coexpression plasmid carrying LKB1 and FUS1 genes on lung cancer in vitro and in vivo

Construction and identification of alpha-fetoprotein antigen epitope modified interleukin-15 lentiviral expression vector

Construction and expression of a eukaryotic expression plasmid containing human CD40 ligand in human hepatocellular carcinoma cell line HepG2 and its effect on apoptosis

[Recombinant Prokaryotic Plasmid Construction and High Expression of FUS1 Gene].

Construction of Lentivirus Vector Containing FUS1 Gene

Construction of Survivin Specific Small Interfering RNA Expression Vector,its Antiproliferative and Proapoptotic Effect on Lung Adenocarcinoma Cells